2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Imaging, Computational Biology, Emerging Technologies, Profiling, Treatment Considerations, Drug Development, Biological Therapies, Antibody Therapy, Biological Processes, Pathogenesis, Hematopoiesis, Immune Mechanism, Molecular Biology, Multi-Systemic Interactions, Clinical Practice (Health Services and Quality), Practice Models, Quality Improvement, Quality of Care, Value, Diseases, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Infectious Diseases, Viral, Research, Fundamental Science, Translational Research, Clinical Research, Health Disparities Research, Study Population, Human, Adult, Pediatric, Animal Model
PAPER

4664 In situ structural basis of hemoglobin S polymerization and red cell sickling revealed through integrative structural biology

Yuan Yee Lee, PhD, Chih-Ta Chien2, Ulrich Baxa3, Zan Chaudhry4, Satish Bodakuntla5, Daniel Orozco6, Christian Biertümpfel7, Naoko Mizuno8, Swee Lay Thein, MD, DSc9
1 Laboratory of Sickle Cell Genetics and Pathophysiology, Hematology Branch, NHLBI, NIH, Bethesda, United States
2 Multi-Institute Cryo-Electron Microscopy Facility (MICEF), NIDDK, NIH, Bethesda, United States
3 Multi-Institute Cryo-Electron Microscopy Facility (MICEF), NIDDK, NIH, Bethesda, United States
4 Laboratory of Structural Cell Biology, NHLBI, NIH, Bethesda, United States
5 Laboratory of Structural Cell Biology, NHLBI, NIH, Bethesda, United States
6 Laboratory of Structural Cell Biology, NHLBI, NIH, Bethesda, United States
7 Laboratory of Structural Cell Biology, NHLBI, NIH, Bethesda, United States
8 Laboratory of Structural Cell Biology, NHLBI, NIH, Bethesda, United States
9 Laboratory of Sickle Cell Genetics and Pathophysiology, Hematology Branch, NHLBI, NIH, Bethesda, United States

Sickle Cell Disease (SCD) is an inherited red cell disorder caused by hemoglobin S (HbS), an abnormal hemoglobin resulting from a single base substitution in the beta hemoglobin gene. SCD affects an estimated 8 million people worldwide, including 100,000 people in the United States. Under low-oxygen conditions, HbS molecules polymerize into rigid fibers that distort red blood cells into the characteristic sickle shape, driving recurrent vaso-occlusive pain crises, hemolytic anemia, and progressive multisystemic organ damage that underlies the premature death. Despite decades of study, how the assembly of HbS at the molecular level translates into the diverse cell shape changes seen in sickling has remained unresolved, in part because HbS polymer structure has never been directly visualized within intact sickled cells.

To address this gap, we combined live-cell imaging with cryo-electron tomography and high-resolution cryo-electron microscopy to directly determine the molecular structure and intracellular organization of HbS polymers within patient-derived sickled red blood cells. Live imaging showed that cells maintained a near-normal shape for a variable period after deoxygenation, then underwent an abrupt sickling transition once deformation began. The morphological change which occurred within 2 seconds, began at a single site within the cell and rapidly spread outward in multiple directions. This process generated not only classical crescent-shaped sickle cells but also branched, “holly-leaf” shapes, indicating that sickling can arise from rapid, localized expansion rather than uniform stretching along a single axis.

Using targeted cryo-focused ion beam milling (cryo-FIB) to prepare thin cellular sections for imaging, combined with high-resolution structural analysis, we resolved the atomic structure of the HbS polymer at 3.6 Å directly within sickled red blood cells, the first direct visualization. A second related population was missing two of the outer strands, revealing variability in how completely these fibers assemble and suggesting that the outer strands attach more loosely. Mapping these near-atomic structures back onto their exact locations and orientations, or structure-guided back-plotting, within cells linked molecular-level detail directly in the cellular environment.

Polymer density varied significantly across regions within individual cells; but even sparse filaments remained clustered together, suggesting that they arise from localized “seeding” or polymerization domains, rather than forming randomly throughout the cell. In denser regions, HbS polymers organized into multiple spatially distinct tightly packed bundles and internally align, although neighboring bundles were not necessarily oriented the same way. Individual polymers were often straight over extended distances but could also curve smoothly. Notably, the ends of the filaments frequently sat within approximately 10 nm of sharply curved regions of the cell-membrane, while the sides of the filaments ran alongside smoother membrane areas, revealing a close spatial structural correspondence between local polymer shape and membrane deformation.

Together, these findings provide the first direct, atomic view of HbS polymer structure inside sickled red blood cells. Our data support a model in which sickling begins at a localized polymerization site that rapidly expands into multiple internally ordered, but overall heterogeneous, filament clusters, generating the abrupt and multidirectional cell deformation, characteristic of sickling. By linking polymer structure, inter-filament organization, membrane shape and real-time deformation, this work establishes a structural framework to guide future drug development aimed at disrupting pathological HbS polymerization.

Future directions include evaluating how anti-sickling agents in clinical development affect membrane deformation, as well as examining how fetal hemoglobin and its inter-cellular distribution influence HbS fiber formation and sickling.
Yuan Yee Lee, PhD: No relevant conflicts of interest to declare.